Your session is about to expire
← Back to Search
Neurofeedback for Post-Concussion Syndrome (NFBVETmTBI Trial)
NFBVETmTBI Trial Summary
This trial will help researchers learn if neurofeedback training can help veterans with mild traumatic brain injury who have chronic post-concussive symptoms.
NFBVETmTBI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowNFBVETmTBI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.NFBVETmTBI Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had a severe traumatic brain injury.You are able to understand what you read.I am a veteran not from OEF-OIF-OND with a mild traumatic brain injury.I am either younger than 18 or older than 60.I often suffer from headaches, have trouble sleeping, and find it hard to concentrate.I am a veteran aged 18-65 with a mild traumatic brain injury.You are a pregnant woman who has served in the military.I have difficulty making decisions due to my health condition.You have indicated that you have thoughts of hurting yourself or have made plans to do so.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- Group 1: NFB Intervention and Delayed Intervention
- Group 2: Control Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
What objectives are the researchers attempting to realize with this research?
"This clinical trial will assess the impact of NEUROQOLTBI Sleep Disturbance short form, via data collection at Baseline, 4-6 weeks in to treatment, 8-10 week endpoint and 2 months post-treatment. Secondary objectives include Patient Health Questionnaire (PHQ)-9 (with scores ranging from 0-27), Depression Anxiety Stress Scale 21(DASS21) with a score varying from 0 -126; as well as General Symptom Inventory (GSI) which ranges between 0 to 118."
To what extent is the current clinical trial being utilized?
"Affirmative. According to clinicaltrials.gov, the recruitment process for this venture is currently in motion, having begun on January 18th 2021 and last revised on November 15th 2022. A total of 72 participants are needed from one medical facility."
What are the eligibility criteria for participation in this experiment?
"To be accepted into the trial, applicants must demonstrate post-concussive symptoms and fall between 18 to 65 years of age. This investigation is expected to include 72 participants in total."
Are there opportunities for enrolment in this experiment currently?
"According to the clinicaltrials.gov website, this trial is presently welcoming participants. The original start date was January 18th 2021 and it has been modified most recently on November 15th 2022."
Is the current recruitment process for this clinical trial open to adults aged 20 and above?
"This clinical study is seeking out adults aged between 18 and 65 for participation."
Share this study with friends
Copy Link
Messenger